Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

3.36
Delayed Data
As of Nov 22
 0.00 / 0.00%
Today’s Change
2.95
Today|||52-Week Range
5.66
-18.64%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.0066.1M15.0M
 
 
 
Depreciation And Amortization399.0K489.0K694.0K955.0K
 
 
 
 
 
 
Operating ExpensesGross Income-399.0K-489.0K----
 
 
 
General Expenses59.1M69.6M81.2M79.3M
 
 
 
 
 
Research And Development46.7M54.2M57.2M59.6M
 
 
 
 
 
Total Operating Expenses59.5M70.1M81.9M80.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-59.5M-70.1M-15.7M-65.3M
 
 
 
 
 
Extraordinary Credit0.00--8.9M0.00
 
 
Interest Expense On Debt52.0K37.0K55.0K68.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-58.9M-69.7M-5.7M-62.1M
 
 
 
 
 
Income Taxes0.00-678.0K-640.0K-411.0K
 
 
 
 
Net Income-58.9M-69.0M-5.0M-61.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS94.0M98.4M125.6M136.7M
 
 
 
 
 
Shares To Calculate EPS Diluted94.0M98.4M125.6M136.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.63-$0.70-$0.04-$0.45
 
 
 
 
 
EPS Diluted-$0.63-$0.70-$0.04-$0.45